Open AccessLimitations of Sniff Nasal Pressure as an Outcome Measurement in Amyotrophic Lateral Sclerosis Patients in a Clinical Trial
Author(s) -
Michael Bauer,
David Czell,
Steffen Hartmann,
Boleslaw Goldman,
D Müller,
Markus Weber
Publication year - 2012
Publication title -
respiration
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.264
H-Index - 81
eISSN - 1423-0356
pISSN - 0025-7931
DOI - 10.1159/000339415
Subject(s) - medicine , amyotrophic lateral sclerosis , vital capacity , clinical trial , supine position , sitting , physical therapy , randomized controlled trial , diffusing capacity , lung function , disease , pathology , lung
The forced vital capacity (FVC) is an established measure in amyotrophic lateral sclerosis (ALS) clinical trials. Recently the sniff nasal inspiratory pressure (SNIP) test has been increasingly used as a respiratory measure.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom